title: [Muscular pain and hypolipidaemic drugs: a cross-sectional study in cardiological outpatient practice].
abstract: OBJECTIVE
  The present study investigates the frequency of reports of muscular pain in cardiological outpatients.
  
  
  METHODS
  During 2003, 510 outpatients were included in this descriptive cross-sectional study.
  
  
  RESULTS
  Of these, 49 (9.6%) reported muscular pain (regardless of the drug received). Among patients treated with hypolipidaemic drugs, 11.3% reported muscular pain (i.e. 12% of patients receiving statins and 8.2% of those receiving fibrates).
  
  
  CONCLUSIONS
  In this study, there was no significant relationship in the frequency of muscular pain between patients receiving and those not receiving a hypolipidaemic drug.
authors.affiliation: Service de Pharmacologie Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Information sur le Médicament, Hôpitaux de Toulouse, Toulouse, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Biga
authors.forename: Philippe
authors.initials: P
authors.lastname: Vigreux
authors.forename: Maryse
authors.initials: M
authors.lastname: Lapeyre-Mestre
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Montastruc
mesh_terms: D000368:Aged; D003430:Cross-Sectional Studies; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced* / Q000453:epidemiology; D010045:Outpatients; D010146:Pain / Q000139:chemically induced* / Q000453:epidemiology; D011358:Product Surveillance, Postmarketing
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents